leisure time -WSS

leisure time

author：knowledge 2025-09-03 05:26:09 - browse：491

Traffic on the Longfellow Bridge and the Kendall Square skyline are seen. -- health coverage from STAT — Michael Dwyer/AP

Around this time three years ago, while most of us navigated pandemic life, real estate developers across Greater Boston looked to life-science laboratories, and saw dollar signs.

The white-collar office workers who’d long filled downtown towers were largely staying home (unless they worked in commercial real estate). The future of cities had rarely been murkier.

But many biotech companies, like Cambridge’s Moderna, were busier than ever, and growing fast. Life-science companies, and the lab buildings that house them, looked like a sure bet for investors. Money poured in to drug companies by the billions — from venture capitalists, the stock market, the National Institutes of Health. And big real estate investors followed, launching a wave of speculative lab development all over Greater Boston.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： H.R. 3 is the wrong path to lower drug costs

WSS

The cancer stories no one wants to hear

What the airline industry can learn from medicine

Canadian Prime Minister Justin Trudeau separating from wife, Sophie

Heart disease in astronauts blamed on cosmic radiation

Hyundai and Kia recall nearly 92,000 vehicles and tell owners to park them outside due to fire risk

Scientists inch closer to single

knowledge

leisure time

entertainment

Guidelines to prevent youth baseball injuries need more muscle

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

Malaria cases in Florida and Texas: Here’s what you need to know

Physician groups backed by private equity giant lobby on mergers

Affirmative action in medical school literally saved lives

Adults seen as increasingly susceptible to measles

Psychedelics group wrestles with new pharma identity

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

Cancer drug shortages should be causing more outrage

Biotech startup Celsius cuts 75% of staff ahead of first trial start

hotspot

Adults seen as increasingly susceptible to measles

Wildfire pollution widens asthma inequities on Long Island

Personalized medicine goes far beyond genetics

‘Oppenheimer’ and the risks of AI in health care

EQRx, failed developer of low

‘Oppenheimer’ and the risks of AI in health care

focus

explore

knowledge

leisure time